688265 南模生物
交易中 09-14 09:31:13
资讯
新帖
简况
南模生物（688265）披露2026年半年度报告，8月31日股价下跌1.87%
证券之星 · 08-31
南模生物（688265）披露2026年半年度报告，8月31日股价下跌1.87%
每周股票复盘：南模生物（688265）Q2收入增23.43%
证券之星 · 08-30
每周股票复盘：南模生物（688265）Q2收入增23.43%
南模生物（688265）2026年中报简析：增收不增利，三费占比上升明显
证券之星 · 08-30
南模生物（688265）2026年中报简析：增收不增利，三费占比上升明显
图解南模生物中报：第二季度单季净利润同比下降56.14%
证券之星 · 08-29
图解南模生物中报：第二季度单季净利润同比下降56.14%
股市必读：南模生物新发布《关于2026年第四次临时股东会的延期公告》
证券之星 · 08-27
股市必读：南模生物新发布《关于2026年第四次临时股东会的延期公告》
南模生物（688265）披露拟出资5900万元参与设立产业投资基金，8月25日股价上涨2.42%
证券之星 · 08-25
南模生物（688265）披露拟出资5900万元参与设立产业投资基金，8月25日股价上涨2.42%
上交所对南模生物下发监管工作函 股价涨8.25%
观点地产网 · 08-20
上交所对南模生物下发监管工作函 股价涨8.25%
上交所就南模生物有关事项下发监管工作函。
格隆汇 · 08-20
上交所就南模生物有关事项下发监管工作函。
股市必读：南模生物新发布《第四届董事会第十次会议决议公告》
证券之星 · 08-17
股市必读：南模生物新发布《第四届董事会第十次会议决议公告》
每周股票复盘：南模生物（688265）上半年净利预降但扣非净利增近八成
证券之星 · 08-16
每周股票复盘：南模生物（688265）上半年净利预降但扣非净利增近八成
南模生物最新公告：拟出资5900万元参设盐城场景创投基金
证券之星 · 08-14
南模生物最新公告：拟出资5900万元参设盐城场景创投基金
8月13日南模生物（688265）龙虎榜数据：机构净买入1450.99万元
证券之星 · 08-13
8月13日南模生物（688265）龙虎榜数据：机构净买入1450.99万元
A股收评：沪指跌0.5%，超4300股下跌！医药股表现活跃，有色金属板块跌幅居前
格隆汇 · 08-13
A股收评：沪指跌0.5%，超4300股下跌！医药股表现活跃，有色金属板块跌幅居前
异动快报：南模生物（688265）8月13日10点35分触及涨停板
证券之星 · 08-13
异动快报：南模生物（688265）8月13日10点35分触及涨停板
CRO概念持续走高 南模生物20%涨停
每日经济新闻 · 08-13
CRO概念持续走高 南模生物20%涨停
股市必读：南模生物新发布《2026年半年度业绩预告的自愿性披露公告》
证券之星 · 08-12
股市必读：南模生物新发布《2026年半年度业绩预告的自愿性披露公告》
破发股南模生物净利预降 2021上市即巅峰国泰海通保荐
中金财经 · 08-11
破发股南模生物净利预降 2021上市即巅峰国泰海通保荐
股市必读：南模生物（688265）预计2026年1-6月营业收入2.16亿元至2.5亿元
证券之星 · 08-11
股市必读：南模生物（688265）预计2026年1-6月营业收入2.16亿元至2.5亿元
南模生物（688265）披露2026年半年度业绩预告，8月10日股价上涨8.51%
证券之星 · 08-10
南模生物（688265）披露2026年半年度业绩预告，8月10日股价上涨8.51%
南模生物(688265.SH)发预减，预计半年度归母净利润800万元至1000万元，同比下降44.96%至55.97%
智通财经 · 08-10
南模生物(688265.SH)发预减，预计半年度归母净利润800万元至1000万元，同比下降44.96%至55.97%
加载更多
公司概况
公司名称：
上海南方模式生物科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2021-12-28
主营业务：
上海南方模式生物科技股份有限公司的主营业务是基因修饰动物模型的研发、生产、销售及提供临床前一站式CRO技术服务。公司的主要产品是常规基因修饰鼠、工具鼠、免疫缺陷鼠、疾病模型鼠、靶点人源化鼠、全人源抗体鼠、定制化模型产品、药物评价及表型分析、SmocMab全人源抗体开发平台、模型繁育、饲养服务、其他模式生物技术服务。
发行价格：
84.62
{"stockData":{"symbol":"688265","market":"SH","secType":"STK","nameCN":"南模生物","latestPrice":36.97,"timestamp":1789349473000,"preClose":37.3,"halted":0,"volume":32750,"delay":0,"changeRate":-0.0088,"floatShares":77963500,"shares":77963500,"eps":0.2867,"marketStatus":"交易中","change":-0.33,"latestTime":"09-14 09:31:13","open":36.91,"high":36.97,"low":36.87,"amount":1209900,"amplitude":0.0027,"askPrice":37.24,"askSize":4,"bidPrice":36.97,"bidSize":11,"shortable":0,"etf":0,"ttmEps":0.2867,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1789356600000},"marketStatusCode":2,"adr":0,"adjPreClose":37.3,"symbolType":"stock_kcb","openAndCloseTimeList":[[1789349400000,1789356600000],[1789362000000,1789369200000]],"highLimit":41.03,"lowLimit":33.57,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":77963513,"isCdr":false,"pbRate":1.69,"roa":"--","peRate":128.950122,"roe":"0.53%","epsLYR":0.42,"committee":-0.304965,"marketValue":2882000000,"turnoverRate":0.0004,"status":1,"floatMarketCap":2882000000},"requestUrl":"/m/hq/s/688265/","defaultTab":"news","newsList":[{"id":"2663072923","title":"南模生物（688265）披露2026年半年度报告，8月31日股价下跌1.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663072923","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663072923?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:47","pubTimestamp":1788173231,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，南模生物报收于39.45元，较前一交易日下跌1.87%，最新总市值为30.76亿元。该股当日开盘39.38元，最高40.2元，最低38.6元，成交额达5953.56万元，换手率为1.94%。近日，南模生物披露《2026年半年度报告》。扣除股份支付影响后的净利润为14,408,524.21元，同比增长63.23%。经营活动产生的现金流量净额为-40,850,243.75元，同比减少1,212.30%。基本每股收益为0.12元/股，稀释每股收益为0.12元/股，同比均下降47.83%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100029607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663904518","title":"每周股票复盘：南模生物（688265）Q2收入增23.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663904518","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663904518?lang=zh_cn&edition=full","pubTime":"2026-08-30 10:10","pubTimestamp":1788055819,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，南模生物报收于40.2元，较上周的42.3元下跌4.96%。业绩披露要点：2026年第二季度主营收入同比上升23.43%，归母净利润同比下降56.14%。关于2026年第四次临时股东会的延期公告原定于2026年8月31日召开的2026年第四次临时股东会，因工作安排需要，延期至2026年9月14日14时30分召开。扣除股份支付影响后的净利润为14,408,524.21元，同比增长63.23%。本次计提减少2026年半年度归属于母公司所有者的净利润710.79万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000004793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663048434","title":"南模生物（688265）2026年中报简析：增收不增利，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2663048434","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663048434?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:16","pubTimestamp":1788041781,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期南模生物发布2026年中报。截至本报告期末，公司营业总收入2.32亿元，同比上升18.73%，归母净利润907.66万元，同比下降50.04%。本报告期南模生物三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达39.82%。去年的净利率为7.47%，算上全部成本后，公司产品或服务的附加值一般。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000002353.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663018663","title":"图解南模生物中报：第二季度单季净利润同比下降56.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663018663","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663018663?lang=zh_cn&edition=full","pubTime":"2026-08-29 01:59","pubTimestamp":1787939946,"startTime":"0","endTime":"0","summary":"证券之星消息，南模生物2026年中报显示，上半年度公司主营收入2.32亿元，同比上升18.73%；归母净利润907.66万元，同比下降50.04%；扣非净利润-384.38万元，同比下降164.99%；其中2026年第二季度，公司单季度主营收入1.33亿元，同比上升23.43%；单季度归母净利润839.3万元，同比下降56.14%；单季度扣非净利润116.06万元，同比下降91.24%；负债率13.94%，投资收益58.91万元，财务费用303.24万元，毛利率54.51%。财报数据概要请见下图:本文数据来源于南模生物2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900005626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662742207","title":"股市必读：南模生物新发布《关于2026年第四次临时股东会的延期公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662742207","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662742207?lang=zh_cn&edition=full","pubTime":"2026-08-27 04:59","pubTimestamp":1787777947,"startTime":"0","endTime":"0","summary":"公司公告汇总：南模生物将2026年第四次临时股东会由8月31日延期至9月14日召开，股权登记日维持为8月24日不变。公司公告汇总关于2026年第四次临时股东会的延期公告上海南方模式生物科技股份有限公司决定将原定于2026年8月31日召开的2026年第四次临时股东会延期至2026年9月14日14时30分召开；股权登记日仍为2026年8月24日；会议地点、召开方式、审议事项等其他事项不变；网络投票时间为2026年9月14日当日交易时段及互联网平台投票时段。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700010068.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662396837","title":"南模生物（688265）披露拟出资5900万元参与设立产业投资基金，8月25日股价上涨2.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662396837","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662396837?lang=zh_cn&edition=full","pubTime":"2026-08-25 19:00","pubTimestamp":1787655626,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘，南模生物报收于41.0元，较前一交易日上涨2.42%，最新总市值为31.97亿元。该股当日开盘39.8元，最高41.49元，最低38.91元，成交额达1.05亿元，换手率为3.33%。近日，南模生物披露《2026年第四次临时股东会会议资料》。公告显示，公司拟作为有限合伙人出资5,900万元参与设立总规模3亿元的盐城市场景创新应用产业投资基金，投资方向为人工智能和生物医药产业。该事项已获董事会审议通过，尚需提交股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500040542.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660238689","title":"上交所对南模生物下发监管工作函 股价涨8.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660238689","media":"观点地产网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660238689?lang=zh_cn&edition=full","pubTime":"2026-08-20 21:28","pubTimestamp":1787232480,"startTime":"0","endTime":"0","summary":"观点网讯：8月20日，上交所就南模生物有关事项下发监管工作函。当日，南模生物股价上涨8.25%。免责声明：本文内容与数据由观点根据公开信息整理，不构成投资建议，使用前请核实。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/estate/integration/2026-08-20/doc-ininysmm8601149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660281412","title":"上交所就南模生物有关事项下发监管工作函。","url":"https://stock-news.laohu8.com/highlight/detail?id=2660281412","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660281412?lang=zh_cn&edition=full","pubTime":"2026-08-20 20:05","pubTimestamp":1787227533,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660117018","title":"股市必读：南模生物新发布《第四届董事会第十次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660117018","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660117018?lang=zh_cn&edition=full","pubTime":"2026-08-17 02:10","pubTimestamp":1786903822,"startTime":"0","endTime":"0","summary":"公司公告汇总：2026年第四次临时股东会定于8月31日召开，股权登记日为8月24日，会议将审议前述投资基金暨关联交易议案，关联股东需回避表决，中小投资者单独计票。会议同时审议通过《关于召开2026年第四次临时股东会的议案》，表决结果为同意10票，反对1票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700000805.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659175026","title":"每周股票复盘：南模生物（688265）上半年净利预降但扣非净利增近八成","url":"https://stock-news.laohu8.com/highlight/detail?id=2659175026","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659175026?lang=zh_cn&edition=full","pubTime":"2026-08-16 02:31","pubTimestamp":1786818669,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，南模生物报收于49.68元，较上周的42.9元上涨15.8%。来自业绩披露要点：南模生物预计上半年净利润800万至1000万元，同比下滑超四成，但扣非后净利增长最高达78.99%。此次为近5个交易日内第2次上榜。公司预计2026年上半年营收同比增长10.34%至27.71%，归母净利润同比下降55.97%至44.96%；若扣除股份支付影响，扣非后净利润为1,300万元至1,580万元，同比增长47.27%至78.99%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600000614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659335149","title":"南模生物最新公告：拟出资5900万元参设盐城场景创投基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2659335149","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659335149?lang=zh_cn&edition=full","pubTime":"2026-08-14 20:00","pubTimestamp":1786708858,"startTime":"0","endTime":"0","summary":"南模生物(688265.SH)公告称，公司拟作为有限合伙人参与设立盐城市场景创新应用产业投资基金合伙企业（有限合伙）（简称“盐城场景创投基金”）。盐城场景创投基金总规模为3亿元，主要在盐城市围绕人工智能和生物医药产业进行投资。公司拟以自有资金认缴出资5900万元，投资完成后将持有盐城场景创投基金约19.67%的财产份额。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400035536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659350158","title":"8月13日南模生物（688265）龙虎榜数据：机构净买入1450.99万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2659350158","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659350158?lang=zh_cn&edition=full","pubTime":"2026-08-13 17:38","pubTimestamp":1786613908,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年8月13日公布的交易公开信息显示，南模生物因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2026年8月13日收盘，南模生物报收于52.42元，上涨20.01%，涨停，换手率7.63%，成交量5.95万手，成交额2.89亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入1450.99万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300029185.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659413975","title":"A股收评：沪指跌0.5%，超4300股下跌！医药股表现活跃，有色金属板块跌幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2659413975","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659413975?lang=zh_cn&edition=full","pubTime":"2026-08-13 15:05","pubTimestamp":1786604700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0501845795.SGD","000819","BK0028","BK0164","BK0201","LU1993786604.SGD","BK0251","BK0127","BK0006","BK0187","LU0067412154.USD","LU2580892862.HKD","BK0216","BK0012","BK0199","LU1807302812.USD","LU1655091616.SGD","688265","LU1580142542.USD","301363","LU0072913022.USD","BK0010","600489","BK0046","BK0242","BK0082","000001","BK0278","LU1781817850.SGD","LU2580892789.USD","BK0183","LU0880133367.SGD","IE00B0JY6N72.USD","BK0188","BK0275","LU1226287529.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659305187","title":"异动快报：南模生物（688265）8月13日10点35分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2659305187","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659305187?lang=zh_cn&edition=full","pubTime":"2026-08-13 10:45","pubTimestamp":1786589124,"startTime":"0","endTime":"0","summary":"证券之星8月13日盘中消息，10点35分南模生物（688265）触及涨停板。其所属行业医疗服务目前上涨。领涨股为博济医药。该股为基因编辑，创新药，基因测序概念热股，当日基因编辑概念上涨3.28%，创新药概念上涨3.02%，基因测序概念上涨2.12%。8月12日的资金流向数据方面，主力资金净流出3038.12万元，占总成交额16.18%，游资资金净流入221.73万元，占总成交额1.18%，散户资金净流入2816.39万元，占总成交额15.0%。近5日资金流向一览见下表：南模生物主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300012538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659187632","title":"CRO概念持续走高 南模生物20%涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2659187632","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659187632?lang=zh_cn&edition=full","pubTime":"2026-08-13 10:44","pubTimestamp":1786589062,"startTime":"0","endTime":"0","summary":"8月13日，CRO概念盘中持续走高，南模生物20%涨停，此前博济医药20%涨停，万邦医药涨18%，近岸蛋白、皓元医药、睿智医药、奥浦迈、百奥赛图涨幅靠前。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608133840218896.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608133840218896.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658912168","title":"股市必读：南模生物新发布《2026年半年度业绩预告的自愿性披露公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658912168","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658912168?lang=zh_cn&edition=full","pubTime":"2026-08-12 01:19","pubTimestamp":1786468750,"startTime":"0","endTime":"0","summary":"公司公告汇总2026年半年度业绩预告的自愿性披露公告上海南方模式生物科技股份有限公司预计2026年上半年实现营业收入21,600万元至25,000万元，同比增长10.34%至27.71%；归属于母公司所有者的净利润为800万元至1,000万元，同比下降55.97%至44.96%；若扣除股份支付影响，扣非后净利润为1,300.00万元至1,580.00万元，同比增长47.27%至78.99%。本次业绩预告未经注册会计师审计。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200001608.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969805","title":"破发股南模生物净利预降 2021上市即巅峰国泰海通保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969805","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658969805?lang=zh_cn&edition=full","pubTime":"2026-08-11 11:17","pubTimestamp":1786418222,"startTime":"0","endTime":"0","summary":"中国经济网北京8月11日讯 南模生物 昨日晚间发布2026年半年度业绩预告的自愿性披露公告。 南模生物上市首日盘中最高价报82.00元，为该股上市以来最高价。 南模生物首次公开发行股票发行费用总额为1.81亿元，其中，保荐及承销费用1.58亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260811/32331205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1147","BK0201","BK0188","688265","BK0184","BK0183","601211","BK0276","BK0216","BK0012","BK1564","IPOS","02611","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658953885","title":"股市必读：南模生物（688265）预计2026年1-6月营业收入2.16亿元至2.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658953885","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658953885?lang=zh_cn&edition=full","pubTime":"2026-08-11 01:18","pubTimestamp":1786382307,"startTime":"0","endTime":"0","summary":"截至2026年8月10日收盘，南模生物报收于46.55元，上涨8.51%，换手率9.13%，成交量7.12万手，成交额3.39亿元。交易信息汇总资金流向8月10日主力资金净流入695.35万元，占总成交额2.05%；游资资金净流入1246.98万元，占总成交额3.68%；散户资金净流出1942.33万元，占总成交额5.73%。业绩披露要点业绩预告南模生物预计2026年1–6月归属净利润盈利800万元至1000万元；营业收入2.16亿元至2.5亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100001249.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658185932","title":"南模生物（688265）披露2026年半年度业绩预告，8月10日股价上涨8.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658185932","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658185932?lang=zh_cn&edition=full","pubTime":"2026-08-10 22:21","pubTimestamp":1786371713,"startTime":"0","endTime":"0","summary":"截至2026年8月10日收盘，南模生物报收于46.55元，较前一交易日上涨8.51%，最新总市值为36.29亿元。该股当日开盘45.0元，最高50.68元，最低43.9元，成交额达3.39亿元，换手率为9.13%。近日，南模生物发布《2026年半年度业绩预告的自愿性披露公告》。公告显示，公司预计2026年上半年实现营业收入21,600万元至25,000万元，同比增长10.34%至27.71%；归属于母公司所有者的净利润为800万元至1,000万元，同比下降55.97%至44.96%。本次业绩预告未经注册会计师审计。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000034185.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658939600","title":"南模生物(688265.SH)发预减，预计半年度归母净利润800万元至1000万元，同比下降44.96%至55.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658939600","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658939600?lang=zh_cn&edition=full","pubTime":"2026-08-10 20:45","pubTimestamp":1786365933,"startTime":"0","endTime":"0","summary":"智通财经APP讯，南模生物 发布2026年半年度业绩预告，公司预计2026年半年度实现归属于母公司所有者的净利润为800万元至1000万元，同比下降44.96%至55.97%。预计2026年半年度扣除股份支付影响后实现归属于母公司所有者的净利润为1300万元至1580万元，同比增长47.27%至78.99%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478171.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"南模生物(688265.SH)发预减，预计半年度归母净利润800万元至1000万元，同比下降44.96%至55.97%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688265"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789349483524,"stockEarnings":[{"period":"1week","weight":-0.0246},{"period":"1month","weight":-0.1461},{"period":"3month","weight":0.1685},{"period":"6month","weight":-0.1412},{"period":"1year","weight":-0.3324},{"period":"ytd","weight":-0.0874}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":-0.0148},{"period":"3month","weight":-0.0356},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0033},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海南方模式生物科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"6285人(较上一季度减少8.11%)","perCapita":"12404股","listingDate":"2021-12-28","address":"上海市浦东新区琥珀路63弄1号6层","registeredCapital":"7796万元","survey":" 上海南方模式生物科技股份有限公司的主营业务是基因修饰动物模型的研发、生产、销售及提供临床前一站式CRO技术服务。公司的主要产品是常规基因修饰鼠、工具鼠、免疫缺陷鼠、疾病模型鼠、靶点人源化鼠、全人源抗体鼠、定制化模型产品、药物评价及表型分析、SmocMab全人源抗体开发平台、模型繁育、饲养服务、其他模式生物技术服务。","listedPrice":84.62},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"南模生物(688265)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供南模生物(688265)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"南模生物,688265,南模生物股票,南模生物股票老虎,南模生物股票老虎国际,南模生物行情,南模生物股票行情,南模生物股价,南模生物股市,南模生物股票价格,南模生物股票交易,南模生物股票购买,南模生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"南模生物(688265)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供南模生物(688265)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}